Connect with us
Reig Jofre reported a 15% drop in profits in the first quarter of 2024, attributed to the absence of a biosimilar development milestone. However, overall growth...
Reig Jofre invests €5.8 million in Leanbio for vertical integration in biotechnology. They increase their stake to 24%, committing to expanding further. The collaboration aims to...
This week the Catalan pharmaceutical company announced an annual growth of 22% in its income until the third quarter of 2023, which amounted to €237 million....
Reig Jofre registered an EBITDA of €30.4 million in 2022, 11% more than in 2021. Spain concentrated 44% of the group's sales, with a 12% increase...
In order to meet the growing demand for the therapy as Stada introduces it in other European countries over the coming months, the companies have agreed...
The performance of the pharmaceutical sector in the third quarter was worse than that of the Ibex35, the Spanish benchmark index, which fell by 0.3% in...
Grifols increases its profits in the first six months of the year. The Spanish multinational, which specializes in the production of plasma derivatives, achieved a profit...
This past year was not a good one for the Spanish pharmaceutical sector. According to a calculation, the six listed companies on the continuous market has...
The pharmaceutical company Reig Jofre increases its turnover by 15%, up to $278 million (€230 million). This result is driven by the purchase of the osteoarticular...